Histopathological modifications following immunotherapy with P 40 in rats bearing DMBA-induced mammary carcinoma
- PMID: 6774883
- DOI: 10.1007/BF01976136
Histopathological modifications following immunotherapy with P 40 in rats bearing DMBA-induced mammary carcinoma
Abstract
Female Sprague-Dawley rats bearing primarily-induced mammary carcinomas were treated with a new immunostimulating agent (P 40). The histopathological modifications encountered in tumors, lymph nodes, liver and spleen are described. Intratumoral injections provoke a more widespread response of the RES, and particularly a more intense reaction in the draining lymph nodes, than systemic treatment.